LDH/L-lactate: NAD+ oxidoreductase (E.C.1.1.1.27) activity in the cystic fluid of benign and malignant ovarian tumours
Jandová, A.; Laurová, L.; Janousková, M.; Novotná, J.; Pezlarová, J.; Skoda, V.; Trnka, V.
Acta Universitatis Carolinae. Medica. Monographia 1977(78 Part 2): 121-123
1977
ISSN/ISBN: 0567-8250 PMID: 615457 Document Number: 114254
Document emailed within 1 workday
Related Documents
Rettori, V.; Van Sickle, M.; Steinberger, A.; Asch, R.H. 1984: Follicle stimulating hormone binding inhibiting activity and inhibin properties of human ovarian cystic and porcine follicular fluid Acta Europaea Fertilitatis 15(2): 93-97Kunze, M.; Büttner, H.H.; Strache, R.R.; Voss, P.; Briese, V.; Schrodt, U. 1988: CEA determination in aspired fluid of cystic ovarian tumors and ovarian cysts and in ascites and serum samples of patients with ovarian tumors Zentralblatt für Gynakologie 110(16): 1006-1012
Bjelland, J.C.; Freundlich, I.M. 1975: Benign cystic right ovarian teratoma Arizona Medicine 32(8): 638-639
Bais, R.; Philcox, M. 1994: Approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes. Part 8. IFCC Method for Lactate Dehydrogenase (l-Lactate: NAD+Oxidoreductase, EC 1.1.1.27). International Federation of Clinical Chemistry (IFCC) European Journal of Clinical Chemistry and Clinical Biochemistry 32(8): 639-655
Bollag, W.; Ott, F. 1975: Vitamin a acid in benign and malignant epithelial tumours of the skin Acta Dermato-Venereologica. Supplementum 74: 163-166
Gorozhanskaia, E.G.; Shapot, V.S. 1971: Characteristics of the lactate dehydrogenase isoenzyme spectrum of malignant and benign human tumors Vestnik Akademii Meditsinskikh Nauk SSSR 26(3): 28-32
Malivanova, T.F.; Litvinov, S.V. 1990: Antibodies to retroviruses of types C and D in female patients with benign and malignant mammary tumours Acta Virologica 34(1): 19-26
Cerný, J.; Jandová, A.; Papez, L.; Pezlarová, J. 1977: Determination of L-lactate: NAD+ - oxidoreductase (E.C.1.1.1.27) and its isoenzymes during pregnancy Acta Universitatis Carolinae. Medica. Monographia 1977(78 Part 2): 117-120
Yanhua, C.; Geater, A.; You, J.; Li, L.; Shaoqiang, Z.; Chongsuvivatwong, V.; Sriplung, H. 2012: Reproductive variables and risk of breast malignant and benign tumours in Yunnan province, China Asian Pacific Journal of Cancer Prevention: Apjcp 13(5): 2179-2184
Al-Sayed, M.M.; El-Sayed, A.A.E.-F.; El-Barbary, T.M.; Hamad, O. 2011: Conservative surgery in patients with malignant ovarian germ cell tumours Journal of the Egyptian Society of Parasitology 41(3): 737-744
Skof, E.; Grasic Kuhar, C.; Cerar, O.; Zakotnik, B. 2004: Survival and fertility of patients with malignant ovarian germ cell tumours European Journal of Gynaecological Oncology 25(6): 702-706
El-Fiky, S.M.; Taha, Y.M. 1977: Cytoenzymology of benign and malignant tumours of the corpus uteri. II. Lysosomal enzymes in relation to Golgi apparatus Gegenbaurs Morphologisches Jahrbuch 123(1): 103-116
O'Gorman, T.; Olaitan, A. 2009: Primary malignant melanoma arising in an ovarian cystic teratoma European Journal of Gynaecological Oncology 30(1): 88-89
Dueñas García, O.Felipe.; Kerckoff Villanueva, H.; Rico Olvera, H.; Lira Plascencia, J. 2007: Benign peritoneal cystic mesothelioma as differential diagnose of an ovarian dependant tumor. Case report and review of the literature Ginecologia y Obstetricia de Mexico 75(2): 111-114
Spinelli, C.; Gadducci, A.; Bonadio, A.G.; Berti, P.; Miccoli, P. 1999: Benign ovarian fibroma associated with free peritoneal fluid and elevated serum CA 125 levels Minerva Ginecologica 51(10): 403-407
Sarkar, S.R. 1982: Nad and nadp independent lactate oxidoreductase in schwartz leukemia ascites cells Acta Biologica et Medica Germanica 41(11): 1085-1086
Stambolis, C. 1979: Benign multilocular cystic nephroma versus cystic nephroblastoma. a review and classification of cystic metanephric neoplasms Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 123(4): 361-364
Blanchet, J.; Fouquette, B. 1979: Case of malignant ovarian cystic teratoma with bilateral immature differentiation Canadian Medical Association Journal 120(11): 1396-1398
Rubin, D.; Warshaw, A.L.; Southern, J.F.; Pins, M.; Compton, C.C.; Lewandrowski, K.B. 1994: Expression of CA 15.3 protein in the cyst contents distinguishes benign from malignant pancreatic mucinous cystic neoplasms Surgery 115(1): 52-55
Pongpornsup, S.; Piyapittayanan, S.; Charoensak, A. 2011: MDCT imaging findings for characterization pancreatic cystic lesion: differentiation between benign and malignant pattern Journal of the Medical Association of Thailand 94(3): 369-378